| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/11/2006 | WO2006048228A1 Method for the generation of virus producing cell lines and cell lines |
| 05/11/2006 | WO2006048017A1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 05/11/2006 | WO2006026451A3 Targeted expression of apoptosis-inducing genes for disease treatment |
| 05/11/2006 | WO2006014737A3 Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 05/11/2006 | WO2005123141A3 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 05/11/2006 | WO2005120520A8 Compositions and methods for diagnosis and treatment of chemotherapy-resistant neoplastic disease |
| 05/11/2006 | WO2005117994A3 Bmp pathway methods and compositions |
| 05/11/2006 | WO2005116212A3 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 05/11/2006 | WO2005112887A3 Composition comprising intercalated functional-active organic compounds |
| 05/11/2006 | WO2005092924A3 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060100153 HSulf-1 nucleic acids, polypeptides and methods of using |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100149 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 05/11/2006 | US20060099709 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 05/11/2006 | US20060099677 DNA/RNA transduction technology and its clinical and basic applications |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099616 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing to skip hybridization |
| 05/11/2006 | US20060099591 Diagnosis of chronic rejection |
| 05/11/2006 | US20060099586 Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer |
| 05/11/2006 | US20060099264 biodegradable; biocompatible; colloids |
| 05/11/2006 | US20060099243 Oral administering; oral delivering active materials to gastrointestinal system; tablet with enteric coating |
| 05/11/2006 | US20060099235 Medical devices and compositions useful for treating or inhibiting restenosis |
| 05/11/2006 | US20060099210 for screening for modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression; polypeptides; polynucleotides; vectors; host cells |
| 05/11/2006 | US20060099195 Tumor cells with increased immunogenicity and uses therfor |
| 05/11/2006 | US20060099194 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 05/11/2006 | US20060099193 Methods and materials for suppressing pain |
| 05/11/2006 | US20060099192 Method for generating an expandable tissue culture from progenitor cells and tissue so generated |
| 05/11/2006 | US20060099189 Anti-cancer virus desensitization method |
| 05/11/2006 | US20060099188 Tumor-specific promoter |
| 05/11/2006 | US20060099187 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |
| 05/11/2006 | US20060099186 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 05/11/2006 | US20060099185 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 05/11/2006 | US20060099184 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 05/11/2006 | US20060099183 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft |
| 05/11/2006 | US20060099182 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 05/11/2006 | US20060099181 Viral vectors having reduced virulence |
| 05/11/2006 | US20060099180 Retroviral delivery system |
| 05/11/2006 | US20060099179 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy |
| 05/11/2006 | US20060099178 Novel use of adenoviruses and nucleic acids coding therefor |
| 05/11/2006 | US20060099175 exhibiting IFNG (interferon gamma) receptor binding activity, comprising peptides having replacements in the amino acid sequences, useful in therapy, in particular for the treatment of respiratory system disorders such as idiopathic pulmonary fibrosis |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099144 Tumor association of MDL-1 and methods |
| 05/11/2006 | US20060099142 Cancer associated araf1 protein kinase and its uses |
| 05/11/2006 | CA2584873A1 Antisense antiviral compounds and methods for treating a filovirus infection |
| 05/11/2006 | CA2584681A1 Pearmease and suicide genes for antitumoral or antiviral treatment |
| 05/11/2006 | CA2584012A1 Process for treating a biological organism |
| 05/10/2006 | EP1655382A2 Colon specific gene and protein |
| 05/10/2006 | EP1655369A1 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655306A1 Protective antigenes and vaccines for the control of multi species tick infestations |
| 05/10/2006 | EP1655035A1 Treatment of heart failure with CSF-1 |
| 05/10/2006 | EP1654366A1 Stem cell beacon |
| 05/10/2006 | EP1654365A1 Vigilant cells |
| 05/10/2006 | EP1654364A2 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 05/10/2006 | EP1654352A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 05/10/2006 | EP1654349A2 Sulfs as modifiers of the beta catenin pathway and methods of use |
| 05/10/2006 | EP1654285A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 05/10/2006 | EP1653989A2 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 05/10/2006 | EP1653808A1 Neurogenin3 and production of pancreatic islet cells |
| 05/10/2006 | EP1653807A2 Dermal micro organs, methods and apparatuses for producing and using the same |
| 05/10/2006 | EP1624899A4 Increased transduction using abc transporter substrates and/or inhibitors |
| 05/10/2006 | EP1441742A4 Axon repair |
| 05/10/2006 | EP1416969A4 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| 05/10/2006 | EP1332219B1 Use of the human lrp/mvp promotor for a vector that can be induced by therapy |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1282641B1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1185297B1 Streptococcus pneumoniae proteins and vaccines |
| 05/10/2006 | EP1150696B1 Genetically engineered herpes virus for the treatment of tumours |
| 05/10/2006 | EP1006782B1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
| 05/10/2006 | EP0988389B1 Method for the production of non-group c adenoviral vectors |
| 05/10/2006 | EP0873049B1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 05/10/2006 | EP0870839B1 Method for gene introduction into target cells by retrovirus |
| 05/10/2006 | CN1771255A Methods and composition for therapeutic use of RNA interference |
| 05/10/2006 | CN1770978A Treatment of HSV-related pathologies using ssDNA |
| 05/10/2006 | CN1769460A Recombinant chimeric eucaryotic expression vector Cb1-Grb7(SH2)-RING and use of anti-tumour gene drug |
| 05/10/2006 | CN1769453A GRFú¿1-32ú®and SS-HbsAg fusion gene combination and its constructed expression system and pharmaceutical preparation |
| 05/10/2006 | CN1769449A Blastocyst implantation related factor and its uses |
| 05/10/2006 | CN1769447A Decoying oligodeoxynucleotides for suppressing chronic granulocyte leukemia STAT5 and its uses |
| 05/10/2006 | CN1769433A Recombinant vesicular stomatitis virus and its uses |
| 05/10/2006 | CN1255552C Method for using human CRYGS gene and its coded products to diagnose and treat lesion of crystalline lens |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255186C New use of gene mutant of human telomerase inverse transcriptase-like component |
| 05/09/2006 | US7041817 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences |
| 05/09/2006 | US7041806 Netrin receptors |
| 05/09/2006 | US7041802 Peptidoglycan recognition proteins |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041654 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041648 Compositions and methods for treating female fertility |
| 05/09/2006 | US7041635 Factor VIII polypeptide |
| 05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
| 05/09/2006 | US7041497 Used in regulation of genes for tissue inflammation, cellular proliferation, differentiation |
| 05/09/2006 | US7041496 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders |
| 05/09/2006 | US7041495 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |